Engineering a photoactivated caspase-7 for rapid induction of apoptosis

Insights

Researchers engineered a light-activated protein switch (L57V) that triggers rapid apoptosis in targeted cells within 60 minutes of blue light exposure. This controlled cell death requires mitochondrial involvement for full commitment.

Area of Science:

  • Cell biology
  • Molecular biology
  • Biotechnology

Background:

  • Apoptosis is a crucial biological process for development, immunity, and disease.
  • Existing methods for controlling apoptosis are limited.
  • Targeted induction of apoptosis is desirable for therapeutic applications.

Discussion:

  • The engineered L57V protein, a fusion of LOV2 and caspase-7, induces rapid apoptosis upon blue light stimulation.
  • Cells exhibit tolerance to short light exposures, indicating a threshold for caspase-7 activity.
  • Bcl-2 overexpression inhibits L57V-induced apoptosis, highlighting the necessity of mitochondrial pathways.

Key Insights:

  • Light-inducible apoptosis offers precise spatiotemporal control over cell death.
  • The L57V system demonstrates the feasibility of optogenetic control of apoptosis.
  • Mitochondrial pathways are essential for complete commitment to apoptosis initiated by caspase-7.

Outlook:

  • Potential applications in cancer therapy and regenerative medicine.
  • Further research into optimizing light delivery and protein expression.
  • Investigating in vivo efficacy and safety of light-activated apoptosis systems.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.